rs2149356

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_138554.5(TLR4):​c.261-468T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.543 in 151,998 control chromosomes in the GnomAD database, including 25,095 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.54 ( 25095 hom., cov: 32)

Consequence

TLR4
NM_138554.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.38

Publications

105 publications found
Variant links:
Genes affected
TLR4 (HGNC:11850): (toll like receptor 4) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. In silico studies have found a particularly strong binding of surface TLR4 with the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease-2019 (COVID-19). This receptor has also been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness, and with susceptibility to age-related macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2020]
TLR4 Gene-Disease associations (from GenCC):
  • inflammatory bowel disease
    Inheritance: AR Classification: LIMITED Submitted by: PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.677 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_138554.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TLR4
NM_138554.5
MANE Select
c.261-468T>G
intron
N/ANP_612564.1O00206-1
TLR4
NM_003266.4
c.141-468T>G
intron
N/ANP_003257.1O00206-2
TLR4
NM_138557.3
c.-340-468T>G
intron
N/ANP_612567.1O00206-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TLR4
ENST00000355622.8
TSL:1 MANE Select
c.261-468T>G
intron
N/AENSP00000363089.5O00206-1
TLR4
ENST00000394487.5
TSL:1
c.141-468T>G
intron
N/AENSP00000377997.4O00206-2
ENSG00000285082
ENST00000697666.1
c.140+3192T>G
intron
N/AENSP00000513391.1A0A8V8TMK6

Frequencies

GnomAD3 genomes
AF:
0.543
AC:
82541
AN:
151880
Hom.:
25102
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.248
Gnomad AMI
AF:
0.793
Gnomad AMR
AF:
0.621
Gnomad ASJ
AF:
0.629
Gnomad EAS
AF:
0.621
Gnomad SAS
AF:
0.628
Gnomad FIN
AF:
0.556
Gnomad MID
AF:
0.665
Gnomad NFE
AF:
0.682
Gnomad OTH
AF:
0.598
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.543
AC:
82549
AN:
151998
Hom.:
25095
Cov.:
32
AF XY:
0.541
AC XY:
40179
AN XY:
74276
show subpopulations
African (AFR)
AF:
0.248
AC:
10268
AN:
41462
American (AMR)
AF:
0.621
AC:
9480
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.629
AC:
2183
AN:
3470
East Asian (EAS)
AF:
0.621
AC:
3207
AN:
5164
South Asian (SAS)
AF:
0.627
AC:
3011
AN:
4802
European-Finnish (FIN)
AF:
0.556
AC:
5875
AN:
10562
Middle Eastern (MID)
AF:
0.670
AC:
197
AN:
294
European-Non Finnish (NFE)
AF:
0.682
AC:
46351
AN:
67964
Other (OTH)
AF:
0.594
AC:
1255
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1673
3346
5019
6692
8365
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
714
1428
2142
2856
3570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.641
Hom.:
32176
Bravo
AF:
0.539
Asia WGS
AF:
0.602
AC:
2093
AN:
3474

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
13
DANN
Benign
0.67
PhyloP100
1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2149356; hg19: chr9-120474199; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.